← Back to Clinical Trials
Recruiting NCT07530354

NCT07530354 A Longitudinal Cohort Study on the Changes of Physiological Mechanisms in Children After Biliary Tract Reconstruction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07530354
Status Recruiting
Phase
Sponsor Wuhan Children's Hospital
Condition Choledochal Cyst
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-05-01
Primary Completion 2035-04

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 16 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-05-01 with a primary completion date of 2035-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Through observational studies, the long-term changes in liver function, metabolic state, immune response and other aspects of children after biliary tract reconstruction during their growth process were systematically explored. The risks of these long-term physiological changes on chronic diseases such as cardiovascular diseases, diabetic diseases and liver cirrhosis in adulthood, as well as their impacts on cognitive function, musculoskeletal health and other aspects were evaluated. How do early physiological changes affect a patient's long-term health? Are there any potential biomarkers that can predict future health outcomes? Based on the research results, preventive and intervention measures that are helpful in reducing the risk of long-term complications are proposed.

Eligibility Criteria

Inclusion Criteria: * Healthy children matched by age and gender were selected as the control group Exclusion Criteria: * Combined with other serious diseases (such as cancer, autoimmune diseases), having obvious liver function abnormalities before surgery or being undergoing other major treatments.

Contact & Investigator

Central Contact

Xueqiang Yan

✉ yanxueqiang1@163.com

📞 +8615871716704

Frequently Asked Questions

Who can join the NCT07530354 clinical trial?

This trial is open to participants of all sexes, up to 16 Years, studying Choledochal Cyst. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07530354 currently recruiting?

Yes, NCT07530354 is actively recruiting participants. Contact the research team at yanxueqiang1@163.com for enrollment information.

Where is the NCT07530354 trial being conducted?

This trial is being conducted at Wuhan, China, Wuhan, China, Wuhan, China.

Who is sponsoring the NCT07530354 clinical trial?

NCT07530354 is sponsored by Wuhan Children's Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology